Scientists dive into immune 'Training Centers' to unlock hepatitis b secrets
NCT ID NCT07240350
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at immune cells from lymph nodes, tonsils, and liver tissue of people with chronic hepatitis B. Researchers want to understand how the germinal centers—the parts of the body that train immune cells—respond to the virus. By analyzing these tissues, they hope to learn why some people cannot clear the infection. This is an observational study, meaning no new treatment is being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal new targets for treatments or vaccines that harness the immune system to fight chronic hepatitis B.
- What could go wrong
- This is an observational study, not a treatment trial. It only collects tissue samples, so it cannot directly lead to a cure or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanfang hospital, Southern Medical university
RECRUITINGGuangzhou, Guangdong, 510515, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New blood test may sharpen diagnosis of autoimmune liver disease
- Two-Drug combo aims to cure chronic hepatitis b
- New injection aims to tame chronic hepatitis b
- Zambia study tracks hepatitis b outcomes in hundreds of patients
- New drug cocktail shows promise for liver cancer in hepatitis b patients
- New shot aims to tame hepatitis b virus